from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0725c/-

LFCtreatmentdescriptionclass of inhibitor

0.880

Amikacinug/mL Amikacintranslation

-0.236

Cap5-10ug/mL Capreomycintranslation

0.511

Rox10-50 ug/mL Roxithromycintranslation

0.660

SM2-5 ug/mL Streptomycintranslation

2.133

Tet5-10 ug/mL Tetracyclinetranslation

0.842

Rif0.2-5ug/mL Rifampicintranscription

0.662

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.176

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.224

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.089

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.218

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.516

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.603

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.516

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.977

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.619

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.560

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.168

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.744

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.209

Nigericin50 uM Nigericinrespiration

-0.363

TRC10-150 ug/mL Triclosanrespiration

-0.082

TRZ10-25 ug/mL Thioridazinerespiration

3.290

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.068

menadione6-10 ug/mL Menadionerespiration

0.326

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.214

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.261

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.210

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.569

NRP_1Non-replicating persistence stage 1dosRassociated

-0.573

Amp0.2mg/mL AmpicillincellWall

0.407

Cephalexin20-100 ug/mL CephalexincellWall

0.168

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.410

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.116

EMB10-20 ug/mL EthambutolcellWall

0.461

Eta12-40 ug/mL EthionamidecellWall

0.690

INH0.2-0.4 ug/mL IsoniazidcellWall

0.787

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.415

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.250

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.119

BZA0.12 mg/mL BenzamidearomaticAmides

-0.424

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.175

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.009

H2O24 mM hydrogen peroxideDNAdamaging

0.455

Levo10 ug/mL LevofloxacinDNAdamaging

0.119

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.173

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.450

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.026

UVUV-irradiationDNAdamaging

0.156

ARP41-4 ug/mL Antitubercular compound ARP4?

0.264

Antimycin12.5-50 ug/mL Antimycin A?

-0.184

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.083

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.341

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.152

PA8240.2-2 ug/mL PA-824?

-0.167

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.081

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.031

Verapamil50 uM Verapamil?

-0.445

mercaptoethanol2 mM 2-Mercaptoethanol?

0.124

methoxatin10-20 ug/mL Methoxatin?